Details for 2022174931

Up to date per 01.04.2026

Actions

Title / Product Name

PEGYLIERTE LIPOSOMEN ZUR AUSLIEFERUNG VON IMMUNOGEN-KODIERENDER RNS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2022174931

EP Publication Number

4066856

E-Number

1535895

Language

PCT Number

Publication Date

05.10.2022 A

07.12.2022 B1

Registration Date

07.12.2022

AT Publication Date

15.12.2022

Application Date

31.08.2011

Registration Number

Priorities

31.08.2010

37882610 P

IPC

A61K 39/39 20060101AFI20220901BHEP

Maximum Duration of Protection

31.08.2031

Owner

GlaxoSmithKline Biologicals SARue de l'Institut, 89 1330 RixensartBE

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

GEALL, Andrew Emeryville, 94662-8097US

VERMA, Ayush Emeryville, 94662-8097US

Information about Fees